We only have this paper's title and publication details.
Read it at the sourceShows effectiveness of ruxolitinib in refractory hemophagocytic lymphohistiocytosis, suggesting new treatment options.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: